Episode 31: ESMO 2025 Commentary: Prostate Cancer

from The View on GU | with Lalani and Wallis · host Dr. Aly-Khan Lalani & Dr. Christopher Wallis

Live from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review the major ESMO 2025 prostate cancer studies, including ENZARAD, EMBARK, CAPItello-291, PSMAddition, and PR21. Together, they unpack their clinical impact and how evolving biomarkers, imaging, and treatment sequencing are redefining standards of care.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, Ipsen, J&J, Merck, Pfizer, Eisai and AbbVie.

Episode metadata supplied by the publisher feed · Published Oct 29, 2025

Embed this episode

Attribution link and audio player

Ready to play

Episode 31: ESMO 2025 Commentary: Prostate Cancer

0:00 30:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The View on GU | with Lalani and Wallis?

This episode is 30 minutes long.

When was this The View on GU | with Lalani and Wallis episode published?

This episode was published on October 29, 2025.

Can I download this The View on GU | with Lalani and Wallis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!